Brief: Bellicum Pharmaceuticals Says M.D. Anderson To Temporarily Halt Research Activity
17/04/2020 11:19
April 17 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O :
* BELLICUM PHARMACEUTICALS - DUE TO COVID-19 GLOBAL
PANDEMIC, M.D.
ANDERSON HAS INFORMED CO OF ITS DECISION TO TEMPORARILY HALT
RESEARCH ACTIVITY
* BELLICUM PHARMACEUTICALS INC - DOES NOT BELIEVE M.D.
ANDERSON'S
HALT IN ACTIVITIES WILL HAVE A SIGNIFICANT IMPACT ON COMPANY'S
PROGRAMS
Source: (https://bit.ly/3cpByBH)
Further company coverage: BLCM.O
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview